
June 18 (Reuters) - Telomir Pharmaceuticals Inc TELO.O:
TELOMIR PHARMACEUTICALS INC - TELOMIR-1 SIGNIFICANTLY INCREASED CELL VIABILITY - SEC FILING
TELOMIR PHARMACEUTICALS INC - TELOMIR-1 NORMALIZED REACTIVE OXYGEN SPECIES IN PROGERIA CELLS - SEC FILING
TELOMIR PHARMACEUTICALS INC - TELOMIR-1 REVERSED CALCIUM OVERLOAD, RESTORING MITOCHONDRIAL FUNCTION - SEC FILING
Source text: [ID:n0001641172-25-015522]